Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
creditor selling of shares, been going on since emergence, sucks.....
added another 21500,
bring my total to 40K, its a hold from here on unless i get some more powder....
Private board, dont know of one for POSC, but ABPIQ on Yahoo worked great as we tracked the BK on Netdocs and see the emergence come to pass this week.....
Uhh?? sorry fell asleep been talking to myself here for awhile... yeah no problems......................
any published news? why the move? other than it should!
Ballots posted for voting.
http://www.srbp.com/accentia/accentia.htm
return required by Sept 17th, Confirmation hearing Sept 22nd 1:00pm EST
Plan is out, Sept 22 Confirmation Hearing
http://www.srbp.com/accentia/687Accentiaplan.pdf
Also NDA as far FDA is concerned New Drug Application
From Wikipedia, the free encyclopedia
I do agree with your explaination a 100% in this case, dealt with many when I had a job, but when in FDA land it has mutiple meanings.
The New Drug Application (NDA) is the vehicle in the United States through which drug sponsors formally propose that the FDA approve a new pharmaceutical for sale and marketing. The goals of the NDA are to provide enough information to permit FDA reviewers to establish the following:
Is the drug safe and effective in its proposed use(s) when used as directed, and do the benefits of the drug outweigh the risks?
Is the drug’s proposed labeling (package insert) appropriate, and what should it contain?
Are the methods used in manufacturing (Good Manufacturing Practice, GMP) the drug and the controls used to maintain the drug’s quality adequate to preserve the drug’s identity, strength, quality, and purity?
http://en.wikipedia.org/wiki/New_Drug_Application
I think the long expected pop
is already in the price. until we see some real revenue numbers I think we are price bound.
Accentia Biopharmaceuticals, Inc. (ABPIQ: Pink Quote) | Tier Change
--------------------------------------------------------------------------------
Tue, Aug 17, 2010 12:00 - Accentia Biopharmaceuticals, Inc. (ABPIQ: Pink Quote) - Tier Change - The symbol, ABPIQ, no longer is classified as Pink Sheets Limited. As of Tue, Aug 17, 2010, ABPIQ resides in the OTCQB tier. You may find a complete list of tier changes at otcmarkets.com.
Accentia Biopharmaceuticals, Inc. (ABPIQ: Pink Quote) | Tier Change
--------------------------------------------------------------------------------
Tue, Aug 17, 2010 12:00 - Accentia Biopharmaceuticals, Inc. (ABPIQ: Pink Quote) - Tier Change - The symbol, ABPIQ, no longer is classified as Pink Sheets Limited. As of Tue, Aug 17, 2010, ABPIQ resides in the OTCQB tier. You may find a complete list of tier changes at otcmarkets.com.
Biovest Bioreactor System
http://finance.yahoo.com/news/Naval-Health-Research-Center-bw-69990411.html?x=0&.v=1
the good news just keeps coming
a lot of chatter over on the prvt yahoo brd on this.... puzzel seems to be meeting completion....
looks like place with an expierence with robbers, oops did I say that.... Im so friggin long on this stock I would be happy with .25 cents a shr!
09/22/2010 next court date
@04:00PM 08-17795-8M1 ACCENTIA BIOPHARMACEUTICALS, INC., ET AL
Atty:CHARLES A. POSTLER
Trustee:UNITED STATES TRUSTEE - TPA, 1
1 - CONFIRMATION
2 - FOURTH APPLICATION FOR COMPENSATION FOR SALAWANCHICK, LLOYD AND SALAWANCHICK, SPECIAL COUNSEL, DOC. #840, FOR THE PERIOD 6/1/10 THROUGH 7/31/10 ($14,117.41/$10,973.13)
pulled from netdoc's
TAMPA, Fla. & MINNEAPOLIS, Aug 05, 2010 (BUSINESS WIRE) -- Biovest
International, Inc. (OTCQB: "BVTI"), a biotechnology company advancing its personalized cancer vaccine targeting non-Hodgkin's lymphoma, today announced that the Company has retained the investment banking firm, ROTH Capital Partners, LLC (ROTH). ROTH has been engaged to assist Biovest in raising capital
as the Company prepares to emerge from Chapter 11 reorganization.
After the exit from BK. Next big step is submital for Biovest BLA Biologic License Application (US FDA). I picked both these guys when investing in DNDN. The time people have invested in the company and the recent settlement with major creditors taking common shrs as payment. Not cancelling common shrs. Also the approach with Orphan Drug status are all positives.
no worries, sounds like you have been off these boards for a while, if you go to the BVTI msg bd here on I hub I posted several links to catch everyone up. I know I look like a friggin pumper. Just trying to get the real word out. I've been long on this stock since feb/09
more reading material
http://gene.md/
all common shares in both companies to remain intact. Already reviewed and approved by the court.
Accentia plant would produce the experimental Revimmune for MS
Read more: Accentia plans drug production plant; Sanofi/Merck JV gets animal health chief; - FierceBiotech http://www.fiercebiotech.com/also-noted/accentia-plans-drug-production-plant-sanofi-merck-jv-gets-animal-health-chief/2010-07-27#ixzz0vTH6LXn6
August to be a busy month
as Accentia and Biovest exxit BK
Good article on Accentia/BioVest
http://www.biopharmaceuticalnews.blogspot.com/
Roth Capital & 09/30 Extension
another delay, gee another suprise extension
Biovest International product gets orphan drug status from FDA
http://www.bizjournals.com/stlouis/othercities/tampabay/stories/2010/07/26/daily2.html
MoneyTV, Imgg
http://www.emergingcompany.com/volume14week27f.htm
Featured Companies
UNGS, IMGG
Under the assumption they have operating cash or just dedicated people like Accentia?
Check out the updates on BVTI.....
http://investorshub.advfn.com/boards/board.aspx?board_id=5105
Adam Feuerstein at it again and thestreet.com. As we have known and seen this A.F. has an agenda, to flop the stock. I prefer the the writings of James Hill MD, @ gene.md a share holder with an extreme education.
I'm long and still holding since my accumlation.
http://gene.md/2010/05/20/biovest-meets-... Due Dilegence is the name of the game
From thestreet.com and comments by chance56
" http://www.thestreet.com/storycomments/10813622/1/biotech-stock-mailbag-ziopharm.html
Please visit Dr. James Hill's explanation of why the 3 month production time is not the partnership hindrance that Adam has portrayed it to be...
http://seekingalpha.com/article/206258-biovest-meets-skeptic-s-requirements-for-the-next-dendreon-part-1
This is one in a four part series that specifically addresses many of the misrepresentations of BiovaxID's potential. All four parts can be viewed on Seeking Alpha or http://gene.md/
There is a great deal of misunderstanding in regards to BiovaxID's data and the financial status of both Biovest and Accentia. Read Hill's articles, read though the court docs (settlement agreement with Laurus, plans of reorganization and disclosure statements), look at existing blood cancer treatments and also FDA regulatory precendents before taking full acceptance of Adam's opinion on this one.
By chance56 on 7/22/10 12:49 PM"
Disclosure Statements its gonna pop......
DS for emergence,
http://www.srbp.com/accentia/accentia.htm
http://www.srbp.com/biovest/biovest.htm
from Yahoo board by mc_m98
Bankruptcy fails to derail biotech opportunists Accentia, Biovest
Read more: Bankruptcy fails to derail biotech opportunists Accentia, Biovest - Tampa Bay Business Journal
http://tampabay.bizjournals.com/tampabay/stories/2010/07/19/story6.html
"New Cancer Vaccine Kills Lymphoma, Now in Phase III Clinical Trials"
July 17th, 2010 by Drew Halley
http://singularityhub.com/2010/07/17/new...
From the Accentia Yahoo mb:
I agree, I think we will test 1.20 again before Aug 9th date. MM's are really squezzing the faint of heart. The old portfolio looked really good when we were pushing 2.00. now it looks rather depressing. Long in at .55 so I have ways to go before I run.
Biovest's Stock Listing Upgraded to OTCQB(TM) Market
http://www.foxbusiness.com/story/markets/industries/health-care/biovests-stock-listing-upgraded-otcqbtm-market/
Order Scheduling Hearing on Disclosure Statement
Hearing scheduled for 8/9/2010 at 01:30 PM at Tampa, FL
emergence is in view
Extention till Aug for lagard creditors.
looking for emergence July 2010
Disclosure Statement - Joint Disclosure Statement for Joint Plan of Reorganization of Biovest International, Inc., Biovax, Inc., AutovaxID, Inc.,
Biolender, LLC, and Biolender II, LLC under Chapter 11 of Title 11, United
States Code Filed by Charles A. Postler on behalf of Debtors AutovaxID, Inc.,
Biolender II, Inc., Biolender, LLC, Biovax, Inc., Biovest International, Inc..
(Postler, Charles) (Entered: 07/02/2010)
in preparation for emergence from BK.
available @ netdocs or thru Accentia Biopharmaceuticals Forum on Yahoo.
it was a great article and places the company in a better light than what is usually portrayed on the Yahoo msg brds
http://www.boston.com/business/healthcare/articles/2010/06/23/fda_to_alter_rules_on_devices/
FDA to alter rules on devices
Manufacturers cite delays, mixed signals
this the one.....
..........
i thought it was within the last week but Im not fiding it, it made specific reference to upper management didn't approve of the way approvals were being made, in as it was taking too long to get from point A to point C and B in between. It was a responce to I think your artical and this poll,
http://www.medicalnewstoday.com/articles/189524.php
looks like its been picked up the MB msg # 18780